|
Market Closed -
Euronext Paris
11:55:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 76.26 EUR | -0.01% |
|
-1.28% | -7.81% |
| 09-02 | Owkin signs AI drug discovery deal with Boehringer for cancer, immunology | RE |
| 09-02 | Sanofi : Gets a Buy rating from Deutsche Bank | ZD |
Chart calendar Sanofi
Upcoming events on Sanofi
| 2026-10-30 | Earnings release - Q3 2026 | |
| 2026-10-30 | Earnings presentation | 08:00 |
| 2027-01-27 | Earnings release - Q4 2026 | |
| 2027-04-22 | Earnings release - Q1 2027 | |
| 2027-07-28 | Earnings release - Q2 2027 |
Past events on Sanofi
| 2026-07-30 | Earnings release - Q2 2026 | |
| 2026-07-30 | Earnings presentation | 07:00 |
| 2026-04-29 | Présentation aux Actionnaires / Analystes | 08:30 |
| 2026-04-28 | Annual General Meeting | |
| 2026-04-28 | Extraordinary General Meeting | |
| 2026-04-23 | Earnings presentation | 07:00 |
| 2026-04-22 | Earnings release - Q1 2026 | |
| 2026-02-10 | Board of Directors Meeting | |
| 2026-01-29 | Earnings presentation | 08:30 |
| 2026-01-28 | Earnings release - Q4 2025 | |
| 2025-12-16 | Information meeting | 11:15 |
| 2025-11-13 | Information meeting | 10:30 |
| 2025-10-24 | Earnings presentation | 08:30 |
| 2025-10-23 | Earnings release - Q3 2025 |
Past dividends on Sanofi
| 2026-05-05 | Ex-dividend date - 4.12 EUR | 00:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 43 070 43 966 -2.04% | 41 081 43 574 -5.72% | 43 626 43 513 0.26% | 47 655 | 50 756 | 53 238 |
|
EBITDA Million EUR | Released Forecast Spread | 14 259 13 722 3.91% | 12 889 13 227 -2.56% | 13 583 13 333 1.88% | 14 737 | 15 679 | 16 992 |
|
EBIT Million EUR | Released Forecast Spread | 12 670 12 363 2.48% | 11 343 12 078 -6.08% | 12 149 12 092 0.47% | 13 221 | 13 930 | 15 115 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 7 038 9 458 -25.59% | 6 997 7 118 -1.7% | 6 020 8 599 -29.99% | 8 699 | 9 681 | 11 157 |
|
Net income Million EUR | Released Forecast Spread | 5 400 7 748 -30.31% | 5 744 7 863 -26.95% | 7 813 8 143 -4.05% | 7 629 | 8 930 | 10 366 |
|
EPS EUR | Released Forecast Spread | 4,31 6,19 -30.32% | 4,59 5,88 -21.96% | 6,40 6,71 -4.63% | 6,28 | 7,21 | 8,34 |
| Announcement Date | 01/02/24 | 30/01/25 | 29/01/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 S1 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 10 564 10 440 1.19% | 9 895 9 748 1.51% | 9 994 9 987 0.07% | 19 889 19 709 0.91% | 12 434 12 237 1.61% | 11 303 11 125 1.6% | 10 509 10 226 2.77% | 11 597 10 891 6.49% | 22 106 21 314 3.72% | 13 175 | 12 467 | 11 335 | 12 150 | 14 125 | 13 050 |
|
EBITDA Million EUR | Released Forecast Spread | 2 428 2 462 -1.38% | 3 251 2 839 14.53% | 2 795 2 603 7.36% | 4 842 4 376 10.64% | 2 695 2 538 6.21% | 3 312 2 881 14.98% | 3 687 3 094 19.17% | 4 086 | 3 026 | ||||||
|
EBIT Million EUR | Released Forecast Spread | 2 078 2 152 -3.44% | 2 902 2 663 8.97% | 2 461 2 587 -4.88% | 5 363 | 4 445 4 138 7.42% | 2 341 2 298 1.86% | 2 967 2 878 3.08% | 3 291 2 971 10.78% | 6 258 5 872 6.57% | 4 304 | 2 769 | 3 255 | 3 435 | 5 030 | 2 530 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 1 070 1 334 -19.79% | 2 158 2 304 -6.34% | 3 512 3 674 -4.41% | -1 155 1 808 -163.9% | 2 003 2 346 -14.6% | 837 2 922 -71.36% | 4 285 | 1 904 | |||||||
|
Net income Million EUR | Released Forecast Spread | 683 4 230 -83.85% | 1 872 1 726 8.48% | 3 939 4 251 -7.35% | 2 802 2 853 -1.79% | -801 1 220 -165.65% | 1 614 1 969 -18.03% | 343 2 172 -84.21% | 2 919 | 3 008 | ||||||
|
EPS EUR | Released Forecast Spread | 0,54 3,36 -83.93% | 1,52 1,39 9.23% | 3,24 3,74 -13.48% | 2,30 2,33 -1.47% | -0,66 0,90 -173.17% | 1,34 1,63 -17.7% | 0,29 1,54 -81.16% | 2,42 | 2,51 | ||||||
| Announcement Date | 30/01/25 | 24/04/25 | 31/07/25 | 31/07/25 | 24/10/25 | 29/01/26 | 23/04/26 | 30/07/26 | 30/07/26 | - | - | - | - | - | - |
| 2026-09-05 |  | Extraordinary General Meeting | |
| 2026-09-06 | | Présentation aux Actionnaires / Analystes | |
| 2026-09-07 | | Board of Directors Meeting | |
| 2026-09-07 | | Extraordinary General Meeting | 02:30 |
| 2026-09-07 | | Extraordinary General Meeting | 02:30 |
| 2026-09-07 | | Extraordinary General Meeting | 02:30 |
| 2026-09-07 | | Information meeting | 00:30 |
| 2026-09-07 | | Extraordinary General Meeting | 02:00 |
| 2026-09-07 | | Earnings presentation | 03:00 |
| 2026-09-07 | | Extraordinary General Meeting | 02:30 |
Past sector events for Sanofi
| 2026-09-04 | | Ex-dividend date - 0.526 CNY | 00:00 |
| 2026-09-04 | | Earnings presentation | 03:00 |
| 2026-09-04 | | Ex-dividend date - 3.6 INR | 00:00 |
| 2026-09-04 | | Ex-dividend date - 0.6 INR | 00:00 |
| 2026-09-04 | | Extraordinary General Meeting | 02:30 |
| 2026-09-04 | | Earnings presentation | 03:00 |
| 2026-09-04 | | Extraordinary General Meeting | 02:45 |
| 2026-09-04 | | Ex-dividend date - 1 INR | 00:00 |
| 2026-09-04 | | Earnings presentation | 03:00 |
| 2026-09-04 | | Earnings presentation | 03:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
- Calendar Sanofi
Select your edition
All financial news and data tailored to specific country editions
